Medicines Formulary

Medicines A–Z

I

Drug name	NICE TAs	Comments
Ipratropium nebulised
Irbesartan tablets
Irinotecan injection	TA307 - Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	For hospital use only
Iron (III) isomaltoside 1000 (Diafer)		Under review.
Iron isomaltoside 1000 (Monofer)
Iron-hydroxide sucrose complex injection (Venofer)
Irriclens
Isatuximab	TA658 - Isatuximab with pomalidomide and dexamethasone for treating relapsed and refractory multiple myeloma
Isoflurane
Isoplex infusion		For use in liver theatres only.

Drug status key

Formulary drugs are allocated a traffic light status. This provides guidance on where clinical and prescribing responsibilities lie in regard to the initiation and maintenance of prescribing.

Grey

Positive NICE TA and/or awaiting local clarification on place in therapy. Please contact your medicines optimisation team for more information.

Red

Initiation and maintenance of prescribing by specialists only.

Amber

Initiation and maintenance of prescribing by specialists and transfer to primary care prescribing when appropriate, or in primary care following a specialists recommendation. Prior to initiation some medicines may require committee agreement or a framework to support safe transfer and maintenance.

Green

Initiation and maintenance of prescribing by specialists, GPs and other qualified clinicians.

Blue

Under review at University Hospitals Birmingham NHS Foundation Trust.